Comparison of the effect of two compounds of Propofol-Remifentanil and Propofol-Hydralazine on volume of blood loss during dacryocystorhinostomy with general anesthesia
Phase 3
Recruiting
- Conditions
- Blood loss during surgery.
- Registration Number
- IRCT20171030037093N30
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
ASA I, II patients who are candidates for DCR surgery
Age range 18 to 80 years
No contraindication for Hydralazine, Remifentanil and Propofol
Consent to participate in the study
Exclusion Criteria
Known allergies to medicines
Having heart disease
Having diabetes mellitus
Obvious anemia
Having hemoglobinopathy
Having polycythemia
Having liver disease
Ischemic cerebrovascular disease
Having respiratory failure
Systemic hypertension
Any complication that may alter the anesthesia program
Occurrence of complications such as heart block, etc. that prohibit or restrict the continuation of the intervention
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bleeding volume. Timepoint: After intervention. Method of measurement: Suction.
- Secondary Outcome Measures
Name Time Method Blood pressure. Timepoint: Before and after intervention. Method of measurement: Non-invasive automatic barometer.;Heart rate. Timepoint: Before and after intervention. Method of measurement: Pulse Oximeter.;Length of staying in recovery. Timepoint: After intervention. Method of measurement: Modified Aldrete Score.;Surgeon satisfaction. Timepoint: After intervention. Method of measurement: likert scale.